ASTRAZENECA PHARMA INDIA
|
ASTRAZENECA PHARMA INDIA Last 5 Year Income Statement History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
INCOME : | |||||
Gross Sales | ₹1,302 Cr | ₹1,008 Cr | ₹809 Cr | ₹817 Cr | ₹835 Cr |
Sales | ₹1,212 Cr | ₹946 Cr | ₹765 Cr | ₹780 Cr | ₹805 Cr |
Job Work/ Contract Receipts | - | - | - | - | - |
Processing Charges / Service Income | ₹90 Cr | ₹61 Cr | ₹44 Cr | ₹32 Cr | ₹31 Cr |
Revenue from property development | - | - | - | - | - |
Other Operational Income | - | - | - | ₹5.00 Cr | ₹0.04 Cr |
Less: Excise Duty | - | - | - | - | - |
Net Sales | ₹1,296 Cr | ₹1,003 Cr | ₹806 Cr | ₹814 Cr | ₹832 Cr |
EXPENDITURE : | |||||
Increase/Decrease in Stock | ₹-34 Cr | ₹-49 Cr | ₹14 Cr | ₹2.95 Cr | ₹-39 Cr |
Raw Material Consumed | ₹624 Cr | ₹404 Cr | ₹291 Cr | ₹284 Cr | ₹339 Cr |
Opening Raw Materials | ₹15 Cr | ₹14 Cr | ₹20 Cr | ₹21 Cr | ₹12 Cr |
Purchases Raw Materials | ₹128 Cr | ₹81 Cr | ₹77 Cr | ₹89 Cr | ₹74 Cr |
Closing Raw Materials | ₹18 Cr | ₹15 Cr | ₹14 Cr | ₹20 Cr | ₹21 Cr |
Other Direct Purchases / Brought in cost | ₹499 Cr | ₹324 Cr | ₹208 Cr | ₹195 Cr | ₹274 Cr |
Other raw material cost | - | - | - | - | - |
Power & Fuel Cost | ₹4.87 Cr | ₹5.54 Cr | ₹8.10 Cr | ₹7.37 Cr | ₹7.72 Cr |
Electricity & Power | ₹4.87 Cr | ₹5.54 Cr | ₹8.10 Cr | ₹7.37 Cr | ₹7.72 Cr |
Oil, Fuel & Natural gas | - | - | - | - | - |
Coals etc | - | - | - | - | - |
Other power & fuel | - | - | - | - | - |
Employee Cost | ₹241 Cr | ₹259 Cr | ₹230 Cr | ₹220 Cr | ₹217 Cr |
Salaries, Wages & Bonus | ₹204 Cr | ₹225 Cr | ₹199 Cr | ₹192 Cr | ₹188 Cr |
Contributions to EPF & Pension Funds | ₹10 Cr | ₹11 Cr | ₹11 Cr | ₹11 Cr | ₹9.58 Cr |
Workmen and Staff Welfare Expenses | ₹20 Cr | ₹16 Cr | ₹13 Cr | ₹11 Cr | ₹14 Cr |
Other Employees Cost | ₹7.02 Cr | ₹7.15 Cr | ₹6.49 Cr | ₹5.87 Cr | ₹4.85 Cr |
Other Manufacturing Expenses | ₹89 Cr | ₹76 Cr | ₹57 Cr | ₹49 Cr | ₹41 Cr |
Sub-contracted / Out sourced services | - | - | - | - | - |
Processing Charges | - | - | - | - | - |
Repairs and Maintenance | ₹6.23 Cr | ₹6.00 Cr | ₹4.94 Cr | ₹6.08 Cr | ₹6.41 Cr |
Packing Material Consumed | ₹4.53 Cr | ₹4.76 Cr | ₹6.68 Cr | ₹7.65 Cr | ₹5.26 Cr |
Other Mfg Exp | ₹79 Cr | ₹65 Cr | ₹46 Cr | ₹36 Cr | ₹29 Cr |
General and Administration Expenses | ₹66 Cr | ₹57 Cr | ₹40 Cr | ₹41 Cr | ₹66 Cr |
Rent , Rates & Taxes | ₹3.22 Cr | ₹2.35 Cr | ₹2.01 Cr | ₹3.02 Cr | ₹3.92 Cr |
Insurance | ₹3.87 Cr | ₹2.95 Cr | ₹2.70 Cr | ₹3.04 Cr | ₹3.01 Cr |
Printing and stationery | - | - | - | - | - |
Professional and legal fees | ₹35 Cr | ₹23 Cr | ₹21 Cr | ₹24 Cr | ₹24 Cr |
Traveling and conveyance | ₹21 Cr | ₹24 Cr | ₹10 Cr | ₹5.78 Cr | ₹31 Cr |
Other Administration | ₹3.60 Cr | ₹3.59 Cr | ₹3.82 Cr | ₹5.31 Cr | ₹3.67 Cr |
Selling and Distribution Expenses | ₹97 Cr | ₹72 Cr | ₹62 Cr | ₹56 Cr | ₹65 Cr |
Advertisement & Sales Promotion | - | - | - | - | - |
Sales Commissions & Incentives | - | - | ₹5.10 Cr | ₹4.74 Cr | ₹4.03 Cr |
Freight and Forwarding | ₹11 Cr | ₹12 Cr | ₹6.27 Cr | ₹5.99 Cr | ₹5.34 Cr |
Handling and Clearing Charges | - | - | - | - | - |
Other Selling Expenses | ₹86 Cr | ₹60 Cr | ₹51 Cr | ₹45 Cr | ₹56 Cr |
Miscellaneous Expenses | ₹21 Cr | ₹14 Cr | ₹17 Cr | ₹18 Cr | ₹15 Cr |
Bad debts /advances written off | - | ₹0.03 Cr | ₹0.29 Cr | - | - |
Provision for doubtful debts | ₹5.44 Cr | ₹1.67 Cr | ₹4.00 Cr | ₹2.72 Cr | ₹1.58 Cr |
Losson disposal of fixed assets(net) | - | - | - | - | - |
Losson foreign exchange fluctuations | ₹0.50 Cr | - | ₹0.13 Cr | ₹0.54 Cr | ₹0.44 Cr |
Losson sale of non-trade current investments | - | - | - | - | - |
Other Miscellaneous Expenses | ₹16 Cr | ₹12 Cr | ₹12 Cr | ₹15 Cr | ₹13 Cr |
Less: Expenses Capitalised | - | - | - | - | - |
Total Expenditure | ₹1,111 Cr | ₹838 Cr | ₹719 Cr | ₹678 Cr | ₹711 Cr |
Operating Profit (Excl OI) | ₹184 Cr | ₹165 Cr | ₹86 Cr | ₹135 Cr | ₹121 Cr |
Other Income | ₹35 Cr | ₹26 Cr | ₹15 Cr | ₹13 Cr | ₹13 Cr |
Interest Received | ₹33 Cr | ₹23 Cr | ₹11 Cr | ₹10 Cr | ₹12 Cr |
Dividend Received | - | - | - | - | - |
Profit on sale of Fixed Assets | ₹0.03 Cr | ₹2.49 Cr | ₹2.82 Cr | ₹2.17 Cr | ₹0.29 Cr |
Profits on sale of Investments | - | - | - | - | - |
Provision Written Back | ₹0.18 Cr | - | - | - | - |
Foreign Exchange Gains | - | ₹0.28 Cr | - | - | - |
Others | ₹2.02 Cr | ₹0.21 Cr | ₹0.46 Cr | ₹0.21 Cr | ₹0.47 Cr |
Operating Profit | ₹219 Cr | ₹191 Cr | ₹101 Cr | ₹148 Cr | ₹134 Cr |
Interest | ₹1.20 Cr | ₹0.63 Cr | ₹0.95 Cr | ₹1.09 Cr | ₹1.14 Cr |
InterestonDebenture / Bonds | - | - | - | - | - |
Interest on Term Loan | - | - | - | - | - |
Intereston Fixed deposits | - | - | - | - | - |
Bank Charges etc | - | - | - | - | - |
Other Interest | ₹1.20 Cr | ₹0.63 Cr | ₹0.95 Cr | ₹1.09 Cr | ₹1.14 Cr |
PBDT | ₹218 Cr | ₹191 Cr | ₹100 Cr | ₹147 Cr | ₹133 Cr |
Depreciation | ₹15 Cr | ₹16 Cr | ₹17 Cr | ₹20 Cr | ₹19 Cr |
Profit Before Taxation & Exceptional Items | ₹203 Cr | ₹174 Cr | ₹83 Cr | ₹127 Cr | ₹114 Cr |
Exceptional Income / Expenses | ₹16 Cr | ₹-40 Cr | - | - | - |
Profit Before Tax | ₹220 Cr | ₹134 Cr | ₹83 Cr | ₹127 Cr | ₹114 Cr |
Provision for Tax | ₹58 Cr | ₹35 Cr | ₹21 Cr | ₹34 Cr | ₹42 Cr |
Current Income Tax | ₹54 Cr | ₹38 Cr | ₹23 Cr | ₹34 Cr | ₹32 Cr |
Deferred Tax | ₹-0.90 Cr | ₹-3.49 Cr | ₹-1.19 Cr | ₹-1.04 Cr | ₹10 Cr |
Other taxes | ₹5.38 Cr | - | - | ₹1.23 Cr | - |
Profit After Tax | ₹162 Cr | ₹99 Cr | ₹62 Cr | ₹93 Cr | ₹72 Cr |
Extra items | - | - | - | - | - |
Adjustments to PAT | - | - | - | - | - |
Profit Balance B/F | ₹456 Cr | ₹379 Cr | ₹324 Cr | ₹232 Cr | ₹168 Cr |
Appropriations | ₹617 Cr | ₹478 Cr | ₹386 Cr | ₹326 Cr | ₹240 Cr |
General Reserves | - | - | - | - | - |
Proposed Equity Dividend | - | - | - | - | - |
Corporate dividend tax | - | - | - | - | ₹0.51 Cr |
Other Appropriation | ₹39 Cr | ₹23 Cr | ₹1.74 Cr | ₹-3.43 Cr | ₹4.92 Cr |
Equity Dividend % | ₹1,200.00 | ₹800.00 | ₹500.00 | ₹100.00 | ₹50.00 |
Earnings Per Share | ₹64.60 | ₹39.72 | ₹24.64 | ₹37.32 | ₹28.88 |
Adjusted EPS | ₹64.60 | ₹39.72 | ₹24.64 | ₹37.32 | ₹28.88 |
Compare Income Statement of peers of ASTRAZENECA PHARMA INDIA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ASTRAZENECA PHARMA INDIA | ₹15,938.6 Cr | -1.9% | -1.9% | 19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 2.9% | 6.4% | 48.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 0.5% | -2.1% | 59.2% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | 2.3% | 1% | 20.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 3.5% | 15.7% | 20.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -0.1% | 2.3% | 41.1% | Stock Analytics |
ASTRAZENECA PHARMA INDIA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ASTRAZENECA PHARMA INDIA | -1.9% |
-1.9% |
19.3% |
SENSEX | -0.7% |
-1.6% |
11.1% |
You may also like the below Video Courses